Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)

Leukemia

Volumn 21, Issue 10, 2007, Pages 2153-2163

  Durig J ^a   Bug, S ^b   Klein Hitpass, L ^a   Boes, T ^a   Jons T ^c   Martin Subero, J I ^b   Harder, L ^b   Baudis, M ^d   Duhrsen U ^a   Siebert, R ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ATM PROTEIN; CASPASE 4; CASPASE 8; CD3 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; DNA; FAS ANTIGEN; HISTONE H2A; HISTONE H2AB; HISTONE H2AE; HISTONE H4; HISTONE H4G; INTERLEUKIN 1BETA CONVERTING ENZYME; NIBRIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 7; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CELL CYCLE REGULATION; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; GENE CLUSTER; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MAPPING; HUMAN; IMMUNOMAGNETIC SEPARATION; LEUKEMOGENESIS; LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA; UPREGULATION;

EID: 34548768750     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404877     Document Type: Article

References (44)

1. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004; 104: 328-335.
2. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269-3274.
3. Soulier J, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F et al. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 2001; 31: 248-254.
4. Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001; 98: 1721-1726.
5. Dearden CE. T-cell prolymphocytic leukemia. Med Oncol 2006; 23 17-22.
6. Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. Blood 1987; 70: 926-931.
7. Croce CM. Role of chromosome translocations in human neoplasia. Cell 1987; 49: 155-156.
8. Pekarsky Y, Hallas C, Croce CM. The role of TCL1 in human T-cell leukemia. Oncogene 2001; 20: 5638-5643.
9. Pekarsky Y, Hallas C, Croce CM. Molecular basis of mature T-cell leukemia. JAMA 2001; 286:2308-2314.
10. Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci USA 1998; 95: 3885-3889.
11. Stankovic T, Taylor AMR, Yuille MR, Vorechovsky I. Recurrent ATM mutations in T-PLL on diverse haplotypes: No support for their germline origin. Blood 2001; 97: 1517-1518.
12. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, BarShira A et al. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 1997; 3: 1155-1159.
13. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S et al. Genomic gains and losses influence expression levels of genes located within the affected regions: A study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005; 19: 1224-1228.
14. Staudt LM. Molecular diagnosis of the hematologic cancers. New Engl J Med 2003; 348: 1777-1785.
15. Walker BA, Leone PE, Jenner MW, Li C, Gonzalez D, Johnson DC et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood, 2006; 108: 1733-1743.
16. Haslinger C, Schweifer N, Stilgenbauer S, Dohner H, Lichter P, Kraut N et al. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 2004; 22: 3937-3949.
17. Jaffe ES, Harris N, Stein H, Vardiman JW. Tumours of Hematopoietic and Lymphoid Tissues. WHO Classification of Tumours. IARC Press: Lyon, 2001.
18. Baudis A, Cleary ML. Progenetix.net: An online repository for molecular cytogenetic aberration data. Bioinformatics 2001; 17: 1228-1229.
19. Baudis M. Online database and bioinformatics toolbox to support data mining in cancer cytogenetics. Biotechniques 2006; 40: 269-270.
20. Schroers R. Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-ell chronic lymphocytic leukemia. Leukemia 2005; 19: 750-758.
21. Wu B. Differential gene expression detection using penalized linear regression models: The improved SAM statistics. Bioinformatics 2005; 21: 1565-1571.
22. Beissbarth T, Speed TP. GOstat: Find statistically overrepresented gene ontologies within a group of germs. Bioinformatics 2004; 20: 1464-1465.
23. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM. Systematic determination of genetic network architecture. Nat Genet 1999; 22: 281-285.
24. Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002; 98, 470-474.
25. Mitelman F. ISCN: An International System for Human Cytogenetic Nomenclature. Karger: Basel, 1995.
26. Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E et al. Genotyping over 100 000 SNPs on a pair of of oligonucleotide arrays. Nat Methods 2004; 1: 109-111.
27. Jöns T, Drenckhahn D. Anion exchanger 2 (AE2) binds to erythrocyte ankyrin and is colocalized with ankyrin along the basolateral plasma membrane of human gastric parietal cells. Eur J Cell Biol 1998; 75: 232-236.
28. De Schouwer PJJC, Dyer MJS, Brito-Babapulle VB, Matutes E, Catovsky D, Yuille MR. T-cell prolymphocytic leukaemia: Antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation. Br J Haematol 2000; 110: 831-838.
29. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of 2 T-cell receptor-alpha chains dual receptor T-cells. Science 1993; 262: 422-424.
30. Vorwerk P, Wex H, Hohmahn B. Mohnike K, Schmidt U, Mittler U. Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia. J Clin Pathol Mol Pathol 2002; 55: 40-45.
31. Sorour A, Brito-Babapulle V, Smedley D, Yuille M, Catovsky D. Unusual breakpoint distribution of 8p abnormalities in T-prolym-phocytic leukemia: A study with YACS mapping to 8p11-p12 Cancer Genet Cytogenet 2000; 121: 128-132.
32. Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T. Foot NJ et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005; 65: 375-378.
33. Murthy SK, DiFrancesco, LM, Ogilvie RT, Demetrick DJ. Loss of heterozygosity associated with uniparental disomy in breast carcinoma. Mod Pathol 2002; 15: 1241-1250.
34. Nielaender I, Martin-Subero JI, Wagner F, Martinez-Climent JA, Siebert R. Partial uniparental disomy: A recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia 2006; 20: 904-905.
35. Di Benedetto M, Bieche I, Deshayes F, Vacher S, Nouet S, Collura V et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 2006; 380: 127-136.
36. Chen YC, Su YN, Chou PC, Chiang WC, Chang MC, Wang LS et al. Overexpression of NBSI contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol Chem 2005; 280: 32505-32511.
37. Ehlers JP, Harbour JW. NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 2005; 11: 1849-1853.
38. Yang MH, Chiang WC, Chou TY, Chang SY, Chen PM, Teng SC et al. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res 2006; 12: 507-515.
39. Saitou M, Sugimoto J, Hatakeyama T, Russo G, Isobe A Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 2000; 19: 2796-2802.
40. Hallas C, Pekarsky Y, Itoyama T, Varnum J, Bichi R, Rothstein JL et al. Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes. Proc Natl Acad Sci USA 1999; 96: 14418-14423.
41. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 2000; 97: 3028-3033.
42. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992; 52: 5368-5372.
43. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F. Rouge C et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res. 2005; 3: 655-667.
44. Hryniewicz-Jankowska A, Czogalla A, Bok E, Sikorsk AF. Ankyrins, multifunctional proteins involved in many cellular pathways. Folia Mistochem Cytobiol 2002; 40: 239-249.